PSAT1 Regulated Oxidation-Reduction Balance Affects the Growth and Prognosis of Epithelial Ovarian Cancer.
Yiqun ZhangJiajia LiXuhui DongDan MengXiuling ZhiLei YuanLiangqing YaoPublished in: OncoTargets and therapy (2020)
Therefore, these results highlight the potential of PSAT1 inhibitors or metabolic substrate deprivation as therapeutic strategies for treating patients with EOC, especially those with advanced stages of cancer.